Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 72, Issue 6, 2001, Pages 1868-1876

  Lai, Wu Wei ^c   Chen, Fen Fen ^a,b   Wu, Ming Ho ^c   Chow, Nan Haw ^c   Su, Wu Chou ^c   Ma, Mi Chia ^c   Su, Pei Fang ^c   Chen, Helen ^c   Lin, Mu Yen ^c   Tseng, Yau Lin ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONBIOLOGICAL MODEL; ONCOGENE NEU; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; TAIWAN; TUMOR CELL; TUMOR EMBOLISM; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; TUMOR MARKERS, BIOLOGICAL;

EID: 0035658821     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03207-6     Document Type: Article

References (22)

1. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications
2. Molecular biologic substaging of stage I lung cancer according to gender and histology
3. Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer
4. Biology of lung cancer
5. A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
6. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas
7. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 pr HER2
8. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinoma
9. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
10. Mediastinal lymph node dissection
11. Revisions in the international system for staging lung cancer
12. Incidence of local recurrence and second primary tumors in resected stage I lung cancer
13. HER2
14. Analysis of survival data: Cox and Weibull models with covariates
15. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression
16. Prognostic markers in resectable non-small cell lung cancer
17. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0M0 non-small cell lung cancer
18. Expression of the ERBB3 gene product in breast cancer
19. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product
20. Multiple roles for phosphoinositide 3-kinases in signal transduction
21. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival
22. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma